Stage IV breast cancer in the era of targeted therapy: Does surgery of the primary tumor matter? Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms

abstract

  • Although a trend toward improved survival with surgery was observed, it was noted most strongly in patients with ER/PR positive and/or HER-2/neu-amplified disease. This suggests that the impact of local control is greatest in the presence of effective targeted therapy, and supports the need for further study to define patient subsets that will benefit most.

publication date

  • March 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4505547

Digital Object Identifier (DOI)

  • 10.1002/cncr.24873

PubMed ID

  • 20101736

Additional Document Info

start page

  • 1226

end page

  • 33

volume

  • 116

number

  • 5